LUMSDAINE ALFRED 4
4 · Ardent Health, Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Ardent Health (ARDT) CFO Alfred Lumsdaine Receives Award of 61,081 Shares
What Happened
- Alfred Lumsdaine, Chief Financial Officer of Ardent Health, Inc. (ARDT), was awarded 61,081 shares on March 11, 2026. The shares were reported as acquired at $0.00 (no cash paid) under a performance-vesting restricted stock unit award.
Key Details
- Transaction date: March 11, 2026; Form 4 filed March 13, 2026 (appears timely).
- Consideration: $0.00 per share; total reported value $0 (award/grant).
- Shares owned following the transaction: not disclosed in the filing.
- Footnote: These 61,081 shares were earned based on 2024 and 2025 performance under RSUs originally granted July 18, 2024; vesting is contingent on continued service through December 31, 2026 (per footnote F1).
- No 10b5-1 plan, tax withholding, or sale information was reported for this transaction.
Context
- This was an award of performance-based restricted stock units, not an open-market purchase or sale. The shares are not yet vested and may be forfeited if service or performance conditions are not met by the vesting date (Dec 31, 2026). Awards like this reflect compensation/retention rather than an immediate vote of confidence via buying or selling.
Insider Transaction Report
Form 4
LUMSDAINE ALFRED
Chief Financial Officer
Transactions
- Award
Common Stock
[F1]2026-03-11+61,081→ 272,228 total
Footnotes (1)
- [F1]Shares earned based on 2024 and 2025 performance under performance vesting restricted stock units awarded on July 18, 2024. Pursuant to the terms of the award, the shares will vest on December 31, 2026 contingent upon service through such date.
Signature
/s/ Stephen C. Petrovich, Attorney-in-Fact|2026-03-13